Skip to main content
Clinical Trials/NCT05122689
NCT05122689CompletedNot Applicable

Influence of Exogenous Dietary Inorganic Nitrate on Downstream Metabolites of the Enteral Microbiome

University Hospital, Essen2 sites in 1 country30 target enrollmentStarted: November 22, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
30
Locations
2
Primary Endpoint
Change of the enteral microbiome composition

Study Overview

Brief Summary

A growing body of data shows that the enteral microbiome has an effect on cardiovascular diseases. Exogenous inorganic dietary nitrate mediates cardioprotective effects and has been shown to have an influence on the oral microbiome. The nutritional aspects of these cardioprotective effects are particularly intriguing since nitrate is abundant in our everyday diet.

Whether dietary nitrate influences the enteral microbiome and downstream metabolites like short-chain fatty acids (SCFA) and TMAO will be investigated in the present study.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
40 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients aged 40-80 years
  • no regular medication intake
  • no chronic diseases

Exclusion Criteria

  • Regular systemic drug intake
  • Active smoking
  • Chronic diseases
  • Acute diarrhea or vomiting
  • Short gut syndrome
  • Pregnancy or breastfeeding

Arms & Interventions

Nitrate

Experimental

Dietary inorganic nitrate (0,12 mmol sodium-nitrate/kg BW/day) dissolved in 200 ml tap water. Supplementation for 30 days.

Intervention: Nitrate (Dietary Supplement)

Outcomes

Primary Outcomes

Change of the enteral microbiome composition

Time Frame: 30 days

Changes in enteral microbiome composition in stool samples at baseline and after 30 days of placebo/verum supplementation. The 16S rRNA amplicon reads obtained from an Illumina MiSeq System will be analyzed using pipeline QIIME2 (v. 2019.1).

Secondary Outcomes

  • Change of the oral microbiome composition(30 days)
  • Change of circulating SCFA levels(30 days)

Investigators

Sponsor
University Hospital, Essen
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials